Fangfang Jin

Discovery of potent and orally bioavailable inhibitors of Human Uric Acid Transporter 1 (hURAT1) and binding mode prediction using homology model

Jianbiao Peng, Qiyue Hu, Chunyan Gu et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 35 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy

Husun Qian, Yixin Fu, Minkang Guo et al. · Molecular Therapy · 2022 · 29 citations · Full text

Life Sciences, Immunology, Oncology +17

Discovery of Imidazoisoindole Derivatives as Highly Potent and Orally Active Indoleamine-2,3-dioxygenase Inhibitors

Wangyang Tu, Fanglong Yang, Guoji Xu et al. · ACS Medicinal Chemistry Letters · 2019 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients

Tian Qin, Yajie Wang, Jianping Deng et al. · Microbiology Spectrum · 2022 · 24 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Coexistence of low levels of HBsAg and high levels of anti-HBs may increase risk of hepatocellular carcinoma in chronic hepatitis B patients with high HBV load

Zi-zheng Jin, Fangfang Jin, Xin Liu et al. · The Brazilian Journal of Infectious Diseases · 2019 · 20 citations · Full text

Medicine, Oncology, Cancer Epidemiology +15